In the current study, our data reveal that PXR promotes viability and reduces DNA damage of liver and colon cancer cells after IR, providing a clue to overcoming radioresistance in liver and colon cancers where PXR is expressed by targeting PXR. The gene discussed is NR1I2; the disease is malignant colon neoplasm.